Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (14713)	9/17/2000 5:33:07 PM
From: Robert K.	Respond to of 17367

This link is a story of 2 family members strickened. This will give everyone a sense of what the trial is up against. You might have to read it a few times to understand it. musa.org Note 1. The time delay to this bpi site(approx 6 hrs) 2. The swiftness of this killer (12hrs) I have no idea if bpi was offered.

To: aknahow who wrote (14713)	9/18/2000 12:57:00 PM
From: Cacaito	Read Replies (1) \| Respond to of 17367

Gw, it is ethically accepted, and VERY commonly use to do trial with minimal oral consent once institutions have agree to "general consent". The most vivid example is the last year trial in Thailand, Caribbean and South Africa using "short term" azt prevention as opposed to the US accepted protocol to prevent Aids virus perinatal transmision. It was considered that the population does not have acces anyway to prevention, so it is morally acceptable to use a "Placebo" group WITHOUT drugs and for sure afectting up to 15% of the probable avoidance of the virus with it, and KNOWINGLY. Thailand goverment up to fund their part of the study and all the subjects received either US standard or "new short term". This trial became a political problem for the nominated US Surgeon General, cause he (happens to be black)was the head at the Center for Disease Control that sponsored the trial and he personally give the go ahead to it. Only oral consent was obatined and "surrogate" consent from care givers/clinicians was accepted. "Surrogate" concern is use everyday in clinical medicine when the patient can not consent, no family is available and intervention goes on anyway (for proven therapies, of course. And this is considered a moral equivalent to the former research consent. The end of the hiv trial prevention was highly succesful and it is now being use worldwide with the sponsorship of Glaxo/Wellcome providing the drug and logistics of distribution free, for the benefit of thousands and probably in few years millions of children. Respect and honor for the affected ones during the trial. Victims of the real world.